Skip to main content
SpringerLink
Log in

The value of visual evoked potentials in optic neuropathy of Graves’ disease

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Visual evoked potentials (VEP) were tested in patients with ophthalmopathy (OP) of Graves’ disease (GD) before treatment and half-a-year and 5-7 yr after orbital decompression (7 patients) or retrobulbar irradiation (3 patients). Five patients not requiring treatment for OP and 16 healthy subjects served as controls. Treatment for OP was given on clinical grounds including decreased visual acuity (VA) indicating optic neuropathy. Before treatment VA was decreased in 5 out of 19 eyes whereas VEP were abnormal in all. The mean latency at N60 both in the operated (83.1±21.6 ms) and in the irradiated groups (80.9±7.0 ms) was significantly different from that in the untreated group (62.6±8.2 ms; p<0.001) and the healthy subjects (58.9±6.3; p<0.001). At P120 only the latency of the operated group differed significantly from that of the other groups (p<0.001). There was a relationship between the eye muscle changes seen on CT scans and the ophthalmopathy score (according to the classification of the American Thyroid Association) and the latency both at N60 and P120. A change from a V-shape to a W-shape of the waves occurred more often in the treated patients before therapy than in the other groups. Two patients had multiphase VEP in both eyes which improved after treatment. After adequate clinical response the visual acuity improved in one of the 5 patients with initially depressed VA. VEP, initially abnormal in all, improved in 7 of the 19 eyes (37%) but further deterioration was observed in 8 (42%). VEP are an objective and a more sensitive sign of optic neuropathy than VA. Improvement of VEP after therapy is remarkably infrequent even after prolonged follow-up. VEP should be always measured when signs of changes in the volume or function of the external eye muscles are present.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mornex R, Orgiazzi J.J. Hyperthyroidism. In: de Vischer M. (Ed), The Thyroid Gland. Raven Press, New York 1980, p. 279.

    Google Scholar 

  2. Trobe J.D, Glaser J.S, Laflamme P. Dysthyroid optic neuropathy. Clinical profile and rationale for management. Arch. Ophthalmol. 96:1199, 1978.

    Article  CAS  PubMed  Google Scholar 

  3. Wijngaarde R., van Lith G.H.M. Pattern EPS in endocrine orbitopathy. Docum. Ophthalmol. 48:327, 1979.

    Article  Google Scholar 

  4. Neigel J.M., Rootman J., Belkin R.I., Nugent R.A., Drance S.M., Beattie C.W., Spinelli J.A. Dysthyroid optic neuropathy. The crowded orbital apex syndrome. Ophthalmology 95:1515, 1988.

    Article  CAS  PubMed  Google Scholar 

  5. Werner S.C. Modification of the classification of the eye changes of Graves’ disease: recommendations of the ad hoc committee of the American Thyroid Association. J. Clin. Endocrinol. Metab. 44:203, 1977.

    Article  CAS  PubMed  Google Scholar 

  6. Walsh T.E., Ogura J.H. Transantral orbital decompression for malignant exophthalmos. Laryngoscope 65:544, 1957.

    Google Scholar 

  7. Grahne B., Lamberg B.-A., Rinne J., Pelkonen R., Liesmaa M., Tommila V. Transantral orbital decompression in the treatment of Graves’ disease. J. Laryngol. Otol. 99:865, 1985.

    Article  CAS  PubMed  Google Scholar 

  8. Lamberg B.-A., Grahne B., Tommila V., Pelkonen R., Rinne J., Liesmaa M., Välimäki M. Orbital decompression in endocrine exophthalmos of Graves’ disease. Acta Endocrinol. (Copenh.) 109: 335, 1985.

    CAS  Google Scholar 

  9. Donaldson S.S., Bagshaw M.A., Kriss J.P. Supervoltage orbital radiotherapy for Graves’ ophthalmopathy. J. Clin. Endocrinol. Metab. 37:276, 1973.

    Article  CAS  PubMed  Google Scholar 

  10. Raitta C., Karhunen U., Seppäläinen A.M. Changes in the electroretinogram and visual evoked potentials during general anaesthesia using enflurane. Graefe’s Arch. Clin. Exp. Ophthalmol. 218: 294, 1982.

    Article  CAS  Google Scholar 

  11. Wright C.E., Williams D.E., Drasdo N., Harding G.F.O. The influence of age on the electroretinogram and visual evoked potentials. Docum. Ophthalmol. 59:365, 1985.

    Article  CAS  Google Scholar 

  12. Day R.M., Carroll F.D. Optic nerve involvement associated with thyroid dysfunction. Arch. Ophthalmol. 67:43, 1962.

    Article  Google Scholar 

  13. Enzmann D., Marshall W.H., Rosenthal R., Kriss J.P. Computed tomography in Graves’ ophthalmopathy. Radiology 770:615, 1976.

    Google Scholar 

  14. Kennerdell J.S., Rosenbaum A.E., El-Hoshy M.H. Apical optic nerve compression of dysthyroid neuropathy on computed tomography. Arch. Ophthalmol. 99:807, 1981.

    Article  CAS  PubMed  Google Scholar 

  15. Feidon S.E., Muramatsu S., Weiner J.M. Clinical classification of Graves’ ophthalmopathy. Identification of risk factors for optic neuropathy. Arch. Opthalmol. 102:1469, 1984.

    Article  Google Scholar 

  16. Trokal S.L, Jakobiec F.A. Correlation of CT scanning and pathological features of ophthalmic Graves’ disease. Ophthalmology 88: 553, 1981.

    Article  Google Scholar 

  17. Feldon S.E., Lee C.P., Muramatsu S.K., Weiner J.M. Quantitative computed tomography of Graves’ oph thalmopathy. Extraocular muscle and orbital fat in development of optic neuropathy. Arch. Ophthalmology 703:213, 1985.

    Article  Google Scholar 

  18. Chiappa K.H., Ropper A.H. Evoked potentials in clinical medicine (First of two parts). N. Engl. J. Med. 306:1205, 1982.

    Article  CAS  PubMed  Google Scholar 

  19. Ladenson P.W., Stakes J.W., Ridgway E.C. Reversible alteration of the visual evoked potential in hypothyroidism. Am. J. Med. 77:1010, 1984.

    Article  CAS  PubMed  Google Scholar 

  20. Panzo G.J., Tomsak R.L. A retrospective review of 26 cases of dysthyroid optic neuropathy. Am. J. Ophthalmol. L96:190, 1983.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Department for Ophthalmology, University Central Hospital, SF-00290, Helsinki, Finland

    Kirsi Setälä & C. Raitta

  2. 3rd Department of Medicine, University Central Hospital, Helsinki, Finland

    M. Välimäki

  3. Department for Diagnostic Radiology, University Central Hospital, Helsinki, Finland

    V. Katevuo

  4. Endocrine Research Laboratory, University of Helsinki, Helsinki, Finland

    B. -A. Lamberg

Authors
  1. Kirsi Setälä
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Raitta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Välimäki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. V. Katevuo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B. -A. Lamberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Setälä, K., Raitta, C., Välimäki, M. et al. The value of visual evoked potentials in optic neuropathy of Graves’ disease. J Endocrinol Invest 15, 821–826 (1992). https://doi.org/10.1007/BF03348812

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03348812

Key-words

Search

Navigation